AI assistant
XWELL, Inc. — Director's Dealing 2020
Apr 21, 2020
35356_dirs_2020-04-21_7125e6a9-76bd-4208-8335-c6c0e26f0599.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XpresSpa Group, Inc. (XSPA)
CIK: 0001410428
Period of Report: 2020-04-16
Reporting Person: Calm.com, Inc. (10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-04-16 | 5.00% Unsecured Convertible Note due 2022 | $3.1 | S | 2500000 | Disposed | Series E Convertible Preferred Stock (1445816) | Direct | |
| 2020-04-20 | Common Stock Warrants | $2 | S | 937500 | Disposed | 2025-01-08 | Common Stock (937500) | Direct |
| 2020-04-20 | Series E Convertible Preferred Stock | $2 | S | 967742 | Disposed | Common Stock (1500000) | Direct |
Footnotes
F1: $2.5 million aggregate principal amount of XpresSpa Group, Inc.'s 5.00% Unsecured Convertible Notes due May 31, 2022 (the "Note"), which is convertible into shares of Series E Convertible Preferred Stock at a conversion price of $2.00 per share.
F2: Subject to receipt of approval of the shareholders of the issuer, the conversion price of the Note may be reduced in connection with certain anti-dilution price protection provisions, resulting in additional shares of Series E Preferred Stock becoming issuable.
F3: The Note is convertible at the holder's option into shares of Series E Preferred Stock at any time and from time to time.
F4: The Note matures on May 31, 2022.
F5: Subject to receipt of approval of the shareholders of the issuer, the exercise price of the Common Stock Warrants may be reduced in connection with certain anti-dilution price protection provisions, resulting in additional shares of Common Stock becoming issuable.
F6: Holder has the right to convert any of the Series E Convertible Preferred at any time and from time to time.
F7: The Series E Convertible Preferred Stock matures on November 13, 2025.